首页 | 官方网站   微博 | 高级检索  
     

结核病专科医院和结防机构二线抗结核药物使用现状调查
引用本文:李文婧,孙强,闫赟,边学峰,张加胜,耿铖,李仁忠. 结核病专科医院和结防机构二线抗结核药物使用现状调查[J]. 中国防痨杂志, 2010, 32(11): 706-709
作者姓名:李文婧  孙强  闫赟  边学峰  张加胜  耿铖  李仁忠
作者单位:1.山东大学卫生管理与政策研究中心/卫生部卫生经济与政策研究重点实验室; 2.山东省济南市疾病预防控制中心; 3.中国疾病预防控制中心结核病预防控制中心;
基金项目:"艾滋病和病毒性肝炎等重大传染病防治
摘    要:目的了解肺结核患者在专科医院治疗与在结防机构治疗期间二线抗结核药的使用情况。方法在全国选取5个省市作为研究地区。采用随机抽样原则对患者病案进行调查,并对知情关键人物进行访谈。结果患者的二线抗结核药物使用比例高达到56.3%;使用的二线药种类较多,其中左氧氟沙星在2个机构中使用最多,分别占到89.6%和81.0%。结论在二线抗结核药物的使用上存在很大问题,因此政府和医院要出台相应政策使二线抗结核药物使用规范化。

关 键 词:医院,专科  结核/药物疗法

Investigation of the second-line anti-TB drugs usage in specialist hospitals and tuberculosis control institutions
Li Wenjing,Sun Qiang,Yan Yun,Bian Xuefeng,Zhang Jiasheng,Geng Cheng,Li Renzhong. Investigation of the second-line anti-TB drugs usage in specialist hospitals and tuberculosis control institutions[J]. The Journal of The Chinese Antituberculosis Association, 2010, 32(11): 706-709
Authors:Li Wenjing  Sun Qiang  Yan Yun  Bian Xuefeng  Zhang Jiasheng  Geng Cheng  Li Renzhong
Affiliation:1.Center for Health Management and Policy; Shandong University; Jinan 250012; China; 2.Jinan Center for Disease Control and Prevention; Jinan 250001; 3.National Center for Tuberculosis Control and Prevention China CDC; Beijing 102206;
Abstract:Objective To understand the use of second-line anti-TB drugs in TB specialist hospitals and tuberculosis control institutions. Methods Five provinces were selected in China as research sites. The patient medical records were randomly selected for investigation, corresponding key persons were interviewed. Results The proportion of second-line anti-TB drug use in patients has already reached 56.3%. There are a variety of second line drugs. Among which, Levofloxacin in two institutions is the mostly used, respectively 89.6% and 81.0%. Conclusion There are a lot of problems existed in second line drug use. Therefore, the government and specialist hospitals should develop relevant policies to restrict the use of second-line anti-TB drugs in TB patients.
Keywords:hospitals, specialist  tuberculosis/drug therapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国防痨杂志》浏览原始摘要信息
点击此处可从《中国防痨杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号